PTC Therapeutics Canada Limited
Registration:
1
of
1
(2026-09-09
to
present)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
To introduce PTC Therapeutics Canada to the British Columbia government, discuss rare disease policy (provincially), the Expensive Drugs for Rare Diseases framework, the Life Sciences and Biomanufacturing strategy, challenges in PKU treatment space, improve timely access to therapies, and identify areas of future collaboration.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Economic Development and Trade, Health
|